China NMPA Product Recall - Implantable Left Ventricular Assist System

Abbott Medical, through its subsidiary Abbott Medical Products (Shanghai) Co., Ltd., has initiated a voluntary Class II recall for its Implantable Left Ventricular Assist System. This critical action, publicized by the National Medical Products Administration (NMPA) on March 28, 2025, addresses a significant malfunction identified within the product's power bank. The affected medical device, holding National Medical Device Registration Certificate No. 20243120384, is being recalled to ensure the highest standards of patient safety and product reliability. Specific details regarding the models, specifications, and batch numbers implicated in this recall are comprehensively outlined in the "Medical Device Recall Event Report Form," which accompanies the official announcement. While the document does not specify inspection dates, the voluntary recall itself serves as a crucial corrective action. A Class II recall signifies a situation where the use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote. Abbott Medical's prompt response, under the oversight of the NMPA, reflects a commitment to identifying and mitigating potential risks associated with their life-sustaining medical devices. This measure requires the company to systematically retrieve affected products from the distribution chain and from users, ensuring that only fully compliant and safe devices remain in circulation. The ongoing collaboration between Abbott Medical and the NMPA aims to protect public health by effectively managing and resolving this product integrity issue.